Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has shown notable performance in the Arizona market, particularly in the Tincture & Sublingual category. The brand maintained its strong position, starting at rank 3 in March and April 2024, before climbing to rank 2 in both May and June 2024. This upward trend is complemented by a steady increase in sales, peaking at $29,717 in June. This indicates a growing consumer preference for Chronic Health's tinctures and sublingual products in Arizona, positioning them as a key player in this category. However, it is worth noting that the brand did not make it into the top 30 in other states or categories, highlighting a regional concentration of their success.
In the Topical category within Arizona, Chronic Health experienced some fluctuations. They began at rank 4 in March 2024, dropped to rank 5 in April, returned to rank 4 in May, and again fell to rank 5 in June. Despite these rank changes, there was a noticeable decline in sales from $48,026 in March to $29,708 in June, suggesting a potential challenge in maintaining consumer interest or facing increased competition. The brand's absence from the top 30 rankings in other states and categories further emphasizes the need for strategic expansion and diversification to sustain long-term growth.
Competitive Landscape
In the Arizona Tincture & Sublingual category, Chronic Health has shown a notable upward trend in rank and sales over the past few months. Starting from a consistent third place in March and April 2024, Chronic Health climbed to second place in May and maintained this position through June 2024. This improvement in rank is significant, especially considering the strong competition from CBD Wellness, which saw a decline from second to fourth place by June 2024, and the dominant Drip Oils + Extracts, which has consistently held the top spot. Chronic Health's sales have also shown a positive trajectory, with a notable increase from $19,521 in April to $29,717 in June 2024, indicating growing consumer preference and market penetration. This competitive landscape highlights Chronic Health's rising prominence and potential for further growth in the Arizona market.
Notable Products
In June 2024, Chronic Health's top-performing product was CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its first-place ranking from May 2024 with notable sales of $654. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC) held steady at the second position, showing a consistent performance since April 2024. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) ranked third, improving from its fifth-place ranking in April 2024. The Indica Pain Relief Ointment (80mg THC, 0.5oz) climbed to fourth place from fifth in May 2024. Lastly, the Indica THC Glycerin Tincture (100mg THC, 1oz) rounded out the top five, maintaining its position from May 2024.